Literature DB >> 28338190

The role of miR-146a in modulating TRAF6-induced inflammation during lupus nephritis.

C-Z Zheng1, Y-B Shu, Y-L Luo, J Luo.   

Abstract

OBJECTIVE: Lupus nephritis (LN) is a major complication of systemic lupus erythematosus (SLE). A previous study showed decreased expression level of microRNA (miR)-146a in LN patients, indicating its possible role in LN pathogenesis. PATIENTS AND METHODS: A total of 98 LN patients were recruited, for the collection of renal tissue samples during biopsy or surgery. Another cohort of 15 patients who had renal tumor resection was recruited as the control group, for the further comparison of expression levels of miR-146a, TRAF6 and p-p65 in tissues. Human glomerular mesangial cells were treated with miR-146a mimics, si-TRAF6 or both, followed by the evaluation of p65, p-p65, IL-1β, IL-6, IL-8 and TNF-α. Transwell assay was performed to detect the effect of mesangial cells on chemotaxis of macrophage.
RESULTS: MiR-146a expression was significantly depressed in renal tissues of LN patients, while TRAF6 expression, macrophage infiltration and p-p65 expression were all elevated as the activity of LN was induced. The up-regulation of miR-146a and/or down-regulation of TRAF6 can significantly inhibit NF-κB transcriptional activity of glomerular mesangial cells, while the gene expressions of IL-1β, IL-6, IL-8 and TNF-α were suppressed.
CONCLUSIONS: The expression of miR-146a in renal tissues of LN patients was significantly depressed, while the transcriptional activity of TRAF6 and NF-κB was enhanced. MiR-146 thus inhibited NF-κB transcriptional activity and inflammatory factor synthesis, and alleviated chemotactic effect towards macrophage via the inhibition of TRAF6 activity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28338190

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  23 in total

1.  miRNA-146a attenuates inflammation in an in vitro spinal cord injury model via inhibition of TLR4 signaling.

Authors:  Ying Tan; Longtan Yu; Chunming Zhang; Kebing Chen; Junfan Lu; Lei Tan
Journal:  Exp Ther Med       Date:  2018-08-22       Impact factor: 2.447

Review 2.  Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.

Authors:  Wenshan Lv; Fan Fan; Yangang Wang; Ezekiel Gonzalez-Fernandez; Chen Wang; Lili Yang; George W Booz; Richard J Roman
Journal:  Physiol Genomics       Date:  2017-11-10       Impact factor: 3.107

3.  Noncoding RNAs in inflammation and colorectal cancer.

Authors:  Shengyun Ma; Tianyun Long; Wendy Jia Men Huang
Journal:  RNA Biol       Date:  2019-12-26       Impact factor: 4.652

Review 4.  Urinary microRNA in kidney disease: utility and roles.

Authors:  In O Sun; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-13

5.  Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis.

Authors:  Javier Perez-Hernandez; Olga Martinez-Arroyo; Ana Ortega; Maria J Forner; Raquel Cortes; Miriam Galera; Miguel A Solis-Salguero; Felipe J Chaves; Josep Redon
Journal:  J Nephrol       Date:  2020-08-16       Impact factor: 3.902

6.  Downregulated miR-203 attenuates IL-β, IL-6, and TNF-α activation in TRAF6-treated human renal mesangial and tubular epithelial cells.

Authors:  Li Zhang; Xingkun Zhang
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

7.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

8.  In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection.

Authors:  Amirhossein Ahmadi; Sharif Moradi
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

Review 9.  Role of Macrophages and Related Cytokines in Kidney Disease.

Authors:  Elena Cantero-Navarro; Sandra Rayego-Mateos; Macarena Orejudo; Lucía Tejedor-Santamaria; Antonio Tejera-Muñoz; Ana Belén Sanz; Laura Marquez-Exposito; Vanessa Marchant; Laura Santos-Sanchez; Jesús Egido; Alberto Ortiz; Teresa Bellon; Raúl R Rodrigues-Diez; Marta Ruiz-Ortega
Journal:  Front Med (Lausanne)       Date:  2021-07-08

10.  Long-Term Decrease of Intraocular Pressure in Rats by Viral Delivery of miR-146a.

Authors:  Coralia Luna; Megan Parker; Pratap Challa; Pedro Gonzalez
Journal:  Transl Vis Sci Technol       Date:  2021-07-01       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.